期刊
CURRENT NEUROPHARMACOLOGY
卷 20, 期 10, 页码 1969-1977出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1570159X20666220302153123
关键词
Schizophrenia; metabolic syndrome; antipsychotics; dyslipidemia; diabetes; retrospective cohort study
资金
- National Natural Science Foundation of China [81671336]
- National Key Research and Development Program [2017YFC0909200]
- Shanghai Science and Technology Innovation Action Plan Medical Innovation Research Special Project [21Y11921200]
This study found that long-term prescriptions of CPZ and CLZ have similar effects on the development of MetS in schizophrenia patients, with the CLZ group showing higher blood pressure levels and a higher incidence of dyslipidemia.
Background: Antipsychotics are known to be associated with metabolic syndromes (MetS). Chlorpromazine (CPZ) and Clozapine (CLZ) are currently the most commonly used antipsychotics in low-income districts of China. However, potential differences in the long-term effects of CPZ and CLZ on MetS in schizophrenia inpatients are not well understood. Here, we aimed to identify any MetS profile differences between long-term schizophrenia patients who were prescribed either CPZ or CLZ at a primary psychiatric hospital. Methods: We recruited a total of 204 male schizophrenia patients who received either CPZ or CLZ. We measured their weight, height, body mass index (BMI), waist circumference (WC), diastolic blood pressure (DBP), and systolic blood pressure (SBP), as well as their biochemical indicators, including fasting blood glucose (FBS), triglycerides (TG), cholesterol (TC), high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c). Results: The MetS prevalence in the CPZ and CLZ groups was 31% and 37.5%, respectively. The CLZ group had significantly higher DBP levels and a higher incidence of dyslipidemia (HDL-c) but lower HDL-c and TC levels than the CPZ group. We also determined that smoking history, BMI, and duration of hospitalisation were risk factors for the development of MetS. Moreover, we found that CPZ and CLZ were correlated with the same risk for developing MetS and that BMI was a vital risk factor of MetS for both the CPZ and CLZ groups. Conclusion: Long-term CPZ and CLZ prescriptions were associated with similar profiles for developing MetS of schizophrenia patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据